FRANCISCO JOSÉ TINAHONES MADUEÑO – ENSAYO CLÍNICO CON MEDICAMENTOS – AMGEN SA
A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessingthe Impact of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein (a)
by prodriguez | Jul 3, 2024 | Clinical Trials, Ensayos Clínicos - A-02 | 0 comments